Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Eccher

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Artificial Intelligence in Medicine|December 11, 2002
A multiple classifier system for early melanoma diagnosisAndrea Sboner, Claudio Eccher, Enrico Blanzieri, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|July 1, 2004
Clinical validation of an automated system for supporting the early diagnosis of melanomaAndrea Sboner, Paolo Bauer, Giuseppe Zumiani, et al.
Artificial Intelligence in Medicine|March 29, 2023
Supporting patients and clinicians during the breast cancer care path with AI: The Arianna solutionMauro Dragoni, Claudio Eccher, Antonella Ferro, et al.
Frontiers in Clinical Diabetes and Healthcare|June 25, 2025
Impact of digital health on Type 2 diabetes management: a randomised controlled trial of the 'TreC Diabete' platform (TELEMECHRON Study)Alexia Giovanazzi, Lorenzo Gios, Maria Adalgisa Gentilini, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 3, 2006
Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experienceSalvatore Mussari, Walter Sabino Della Sala, Lucia Busana, et al.
BMJ Open|May 31, 2017
Optimisation and validation of a remote monitoring system (Onco-TreC) for home-based management of oral anticancer therapies: an Italian multicentre feasibility studyAlessandro Passardi, Mimma Rizzo, Francesca Maines, et al.
Virchows Archiv : an International Journal of Pathology|June 30, 2012
PI3KCA mutations and/or PTEN loss in Her2-positive breast carcinomas treated with trastuzumab are not related to resistance to anti-Her2 therapyMattia Barbareschi, Lucia Veronica Cuorvo, Salvatore Girlando, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 5, 2011
Diagnostic value of automated Her2 evaluation in breast cancer: a study on 272 equivocal (score 2+) Her2 immunoreactive cases using an FDA approved systemChiara Cantaloni, Eugenia Tonini R, Claudio Eccher, et al.
Journal of Medical Internet Research|January 26, 2022
A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training-Validation TrialAlessandro Passardi, Flavia Foca, Orazio Caffo, et al.
Journal of Medical Internet Research|May 15, 2015
Integrating mHealth in Oncology: Experience in the Province of TrentoEnzo Galligioni, Enrico Maria Piras, Michele Galvagni, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Artificial Intelligence in Medicine|December 11, 2002
A multiple classifier system for early melanoma diagnosisAndrea Sboner, Claudio Eccher, Enrico Blanzieri, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|July 1, 2004
Clinical validation of an automated system for supporting the early diagnosis of melanomaAndrea Sboner, Paolo Bauer, Giuseppe Zumiani, et al.
Artificial Intelligence in Medicine|March 29, 2023
Supporting patients and clinicians during the breast cancer care path with AI: The Arianna solutionMauro Dragoni, Claudio Eccher, Antonella Ferro, et al.
Frontiers in Clinical Diabetes and Healthcare|June 25, 2025
Impact of digital health on Type 2 diabetes management: a randomised controlled trial of the 'TreC Diabete' platform (TELEMECHRON Study)Alexia Giovanazzi, Lorenzo Gios, Maria Adalgisa Gentilini, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 3, 2006
Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experienceSalvatore Mussari, Walter Sabino Della Sala, Lucia Busana, et al.
BMJ Open|May 31, 2017
Optimisation and validation of a remote monitoring system (Onco-TreC) for home-based management of oral anticancer therapies: an Italian multicentre feasibility studyAlessandro Passardi, Mimma Rizzo, Francesca Maines, et al.
Virchows Archiv : an International Journal of Pathology|June 30, 2012
PI3KCA mutations and/or PTEN loss in Her2-positive breast carcinomas treated with trastuzumab are not related to resistance to anti-Her2 therapyMattia Barbareschi, Lucia Veronica Cuorvo, Salvatore Girlando, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 5, 2011
Diagnostic value of automated Her2 evaluation in breast cancer: a study on 272 equivocal (score 2+) Her2 immunoreactive cases using an FDA approved systemChiara Cantaloni, Eugenia Tonini R, Claudio Eccher, et al.
Journal of Medical Internet Research|January 26, 2022
A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training-Validation TrialAlessandro Passardi, Flavia Foca, Orazio Caffo, et al.
Journal of Medical Internet Research|May 15, 2015
Integrating mHealth in Oncology: Experience in the Province of TrentoEnzo Galligioni, Enrico Maria Piras, Michele Galvagni, et al.
Pageof 4